Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer

Por de Boer, S M, Wortman, B G, Bosse, T, Powell, M E, Singh, N, Hollema, H, Wilson, G, Chowdhury, M N, Mileshkin, L, Pyman, J, Katsaros, D, Carinelli, S, Fyles, A, McLachlin, C M, Haie-Meder, C, Duvillard, P, Nout, R A, Verhoeven-Adema, K W, Putter, H, Creutzberg, C L, Smit, V T H B M
Publicado no Ann Oncol (2018)